# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 221: Amendment of regulation 327 (powers of inspection, sampling and seizure)

Extent: E+W+S+N.I.

(1) Regulation 327 is amended as follows.
(2) In paragraph (1)(c)—
(a) in paragraph (v), insert “ UK ” before “marketing authorisation”;
(b) after paragraph (v), insert—
“(va) an EU marketing authorisation;”.
(3) In paragraph (2)(g), after paragraph (iv) insert—
“(iva) the requirements of Schedule 12A (further provision as to the performance of pharmacovigilance activities);”.
(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/221 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-221
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.